Erlotinib Versus Etoposide/Cisplatin With Radiation Therapy in Unresectable Stage III Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter, Randomized, Open-Label, Phase 2 Trial
収録刊行物
-
- International Journal of Radiation Oncology*Biology*Physics
-
International Journal of Radiation Oncology*Biology*Physics 109 (5), 1349-1358, 2021-04
Elsevier BV